Enrolling by invitationNot applicableNCT07102849
Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study
Studying VEXAS syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Principal Investigator
- Bhavisha A Patel, M.D.National Heart, Lung, and Blood Institute (NHLBI)
- Enrollment
- 1400 enrolled
- Eligibility
- 2-120 years · All sexes
- Timeline
- 2025 – 2030
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07102849 on ClinicalTrials.govOther trials for VEXAS syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06782373A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Swedish Orphan Biovitrum
- RECRUITINGPHASE1NCT06538181Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeWashington University School of Medicine
- RECRUITINGNCT06657846HRQoL and Financial Toxicity in Patients With VEXAS SyndromeGruppo Italiano Malattie EMatologiche dell'Adulto
- RECRUITINGNCT06377462Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial CollectionTechnische Universität Dresden